Veridex, LLC
1001 Route 202
Raritan
New Jersey
08869-0606
United States
Tel: 877-VERIDEX
Fax: 908-595-2486
Website: http://www.veridex.com/
25 articles about Veridex, LLC
-
Advaxis Taps Kenneth Berlin as New CEO
4/23/2018
After nearly a year without a permanent chief executive officer Advaxis, Inc. has a new hand on the wheel. This morning the company announced Kenneth A. Berlin will take over the helm of the company as president and CEO effective immediately. -
Arno Therapeutics to Collaborate With Veridex, LLC on Development of Diagnostic Test
6/3/2013
-
Veridex, LLC Release: Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study
4/4/2013
-
Veridex, LLC and LabCorp Agreement Brings CELLSEARCH® CTC Test to China
1/17/2013
-
Veridex, LLC Release: New Category I CPT Codes and Payment Rates for Circulating Tumor Cell Testing Effective January 1
12/27/2012
-
Veridex, LLC, a Johnson & Johnson Company, Gains OK for Cancer IVD Test in China
12/14/2012
-
Veridex, LLC Release: CellSearch® "Liquid Biopsy" Approved for Breast Cancer Patients in China
12/13/2012
-
Veridex, LLC Release: Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing
8/10/2012
-
New Veridex, LLC Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
4/24/2012
-
Veridex, LLC Release: Late-Breaking American Society of Clinical Oncology Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
6/6/2011
-
Veridex, LLC Launches CELLTRACKS(R) Circulating Melanoma Cell Kit for Research Use
5/25/2011
-
Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital
1/3/2011
-
Veridex, LLC: Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer
7/13/2009
-
Nuvera Biosciences Licenses Therapy-Directed Diagnostic Tests in Breast Cancer to Veridex, LLC
4/6/2009
-
Veridex, LLC Test Monitors Prostate Cancer Chemotherapy Effects, Memorial Sloan-Kettering Cancer Center Study
2/11/2009
-
Veridex, LLC Completes Acquisition of Immunicon Corporation Assets
8/4/2008
-
Veridex, LLC New Gene Methylation Test for Prostate Cancer Available
5/19/2008
-
Veridex, LLC and Laboratory Corporation of America Holdings New Gene Methylation Test for Prostate Cancer Available
5/16/2008
-
Immunicon Corporation Announces Final Decision In Its Arbitration Proceeding Against Veridex, LLC
3/4/2008
-
FDA Clears Veridex, LLC Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
2/28/2008